NCT01562405 Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01559935 Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma Status COMPLETED Phase PHASE2
NCT01556438 Study of Tabalumab (LY2127399) in Japanese Participants With Relapsed or Refactory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01555281 Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma Status TERMINATED Phase PHASE1/PHASE2
NCT01549431 Study of the Combination of Panobinostat & Carfilzomib in Patients With Relapsed &/or Refractory Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01548573 Tandem Auto Transplantation in Myeloma Patients With <12 Months of Prior Treatment Status TERMINATED Phase PHASE2
NCT01543945 Prevention Post Operative Nausea Vomiting in Ambulatory Gynecologic Laparoscopy Status COMPLETED Phase PHASE2
NCT01541332 Pomalidomide, Dexamethasone and Pegylated Liposomal Doxorubicin for Relapsed/Refractory Multiple Myeloma Status UNKNOWN Phase PHASE1/PHASE2
NCT01538459 Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block Status WITHDRAWN Phase PHASE3
NCT01537861 Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma Status TERMINATED Phase EARLY_PHASE1
NCT01534169 Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients Status COMPLETED Phase PHASE1
NCT01531998 Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) Status COMPLETED Phase PHASE1/PHASE2
NCT01527149 Ofatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT01526694 Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM Status COMPLETED Phase PHASE2
NCT01525069 Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma Status TERMINATED Phase PHASE1
NCT01524731 The Effect of Prophylactic Antiemetic Dexamethasone on Plasma Cortisol Levels Status COMPLETED Phase NA
NCT01518465 Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma Status TERMINATED Phase PHASE2
NCT01511211 Duration of Leg Nerve Blocks With Dexamethasone Added to Local Anesthetic Status WITHDRAWN Phase PHASE4